Prognostic Value of Soluble Urokinase Plasminogen Activation Receptor (SUPAR) to Rule Out Complications in Patients Admitted in Emergency Department for Acute Abdominal Pain.

NCT05580016 · clinicaltrials.gov ↗

COMPLETED

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Soluble Urokinase Plasminogen Activation Receptor
Abdominal Pain
Emergency Department
Mortality

Interventions

DIAGNOSTIC_TEST: Soluble Urokinase Plasminogen Activation Receptor measurement

Sponsor

Poitiers University Hospital